NCT00127296
- Conditions
- Delivery Systems, Diabetes, Diabetes Mellitus, +5 more
- Locations
-
- Novo Nordisk Investigational Site San Antonio, Texas, United States
Clinical trial condition
Diabetes Mellitus, Type 2
Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.
2,679 public trials
158 recruiting studies
Diabetes Mellitus, Type 2 trial results
NCT01548235
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Copenhagen S, Denmark
Completed
Basal Bolus of Insulin Aspart Including Insulin NPH and Biphasic Insulin Aspart in Type 2 Diabetes
NCT00600626
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Zagreb, Croatia
- Novo Nordisk Investigational Site Lille, France
- Novo Nordisk Investigational Site Nevers, France
- Novo Nordisk Investigational Site Rennes, France
NCT01526980
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Newcastle, United Kingdom
Completed
Comparison of Biphasic Insulin Aspart 70/30, 50/50, and 30/70 in Subjects With Type 2 Diabetes
NCT00184574
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Bregenz, Austria
- Novo Nordisk Investigational Site Feldkirch, Austria
- Novo Nordisk Investigational Site Graz, Austria
- Novo Nordisk Investigational Site Salzburg, Austria
NCT01620424
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Tokyo, Japan
NCT01467323
- Conditions
- Autoimmune Diseases, Diabetes, Diabetes Mellitus, +7 more
- Locations
-
- Novo Nordisk Investigational Site Graz, Austria
- Novo Nordisk Investigational Site Vienna, Austria
- Novo Nordisk Investigational Site Anklam, Germany
- Novo Nordisk Investigational Site Berlin, Germany
NCT00095446
- Conditions
- Autoimmune Diseases, Diabetes, Diabetes Mellitus, +7 more
- Locations
-
- Novo Nordisk Investigational Site Princeton, New Jersey, United States
Completed
Comparison of Biphasic Human Insulin 30 With Biphasic Insulin Aspart in Subjects With Diabetes
NCT01520818
- Conditions
- Autoimmune Diseases, Diabetes, Diabetes Mellitus, +7 more
- Locations
-
- Novo Nordisk Investigational Site Aalst, Belgium
- Novo Nordisk Investigational Site Brussels, Belgium
- Novo Nordisk Investigational Site Brussels, Belgium
- Novo Nordisk Investigational Site Edegem, Belgium
NCT01520753
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Århus C, Denmark